Searched for
GYNAECOLOGY
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...
- Sir H.N. Reliance Foundation Hospital Claims Top Spot In Nationwide Critical Care SurveySir H.N. Reliance Foundation Hospital has been ranked the country's leading multi-specialty institution in the Times of India Critical Care...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%, according to analystsThis is easy to say, but difficult to actually implement: As an investor, make a distinction between the day-to-day movement of indices and...
- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Temasek, TPG look to admit more investors to CloudnineTemasek and TPG Newquest are on the hunt for new financial partners for Cloudnine Hospitals, a premier name in mother and child healthcare....
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Aster DM Healthcare invests Rs 96 crore to expand Whitefield facility; capacity to increase to 539 bedsAster DM Healthcare has invested Rs 96 crore to expand its women and children facility at Aster Whitefield Hospital in Bengaluru. The hospi...
- Women don’t pause: Menopause is moving out of the shadows as women midlifers create conversations, content & community around itAnkita Wamburkar’s struggle with unexplained health issues—initially misdiagnosed—highlights a wider gap in menopause awareness. Her eventu...
- US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore dealUS private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is ...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- Shield Healthcare acquires two entities for undisclosed sumFollowing the acquisitions, Shield Healthcare aims to increase its presence in gynaecology and paediatrics, a company release said here on ...
- 40 Ayurveda hospitals in Rajasthan didn't admit any patient for 5 consecutive years: CAGScrutiny of deployment of manpower in healthcare centres in the state as of March 2017 revealed that deployment was disproportionate.
- Novartis divests anti-infectives brands to Samara CapitalThe portfolio of brands acquired focus on anti-infectives largely catering to the women's health and gynaecology segment, the spokesperson ...
- Declining sex ratio cause for concern: K ChiranjeeviThe declining sex ratio in the country was a cause for alarm, Union Minister of State for Tourism K Chiranjeevi said here today.
- Lupin enters gynaecology segmentDrug major Lupin on Wednesday said its domestic business will continue to focus on lifestyle segment and it has entered the gynaecology seg...
Load More
